| MeSH term | MeSH ID | Detail |
|---|---|---|
| Atherosclerosis | D050197 | 85 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Glioma | D005910 | 112 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Chen T and Feng X | Cell-based assay strategy for identification of motif-specific RANK signaling pathway inhibitors. | 2006 | Assay Drug Dev Technol | pmid:16945019 |
| Schoppet M et al. | Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis. | 2006 | Atherosclerosis | pmid:16325821 |
| Nybo M and Rasmussen LM | Osteoprotegerin released from the vascular wall by heparin mainly derives from vascular smooth muscle cells. | 2008 | Atherosclerosis | pmid:18490020 |
| Fontes JD et al. | Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study. | 2013 | Atherosclerosis | pmid:23489346 |
| Lommi JI et al. | High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification. | 2011 | Atherosclerosis | pmid:21917259 |
| Toffoli B et al. | Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop. | 2011 | Atherosclerosis | pmid:21679949 |
| Shargorodsky M et al. | Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women. | 2009 | Atherosclerosis | pmid:19062016 |
| Koo HM et al. | Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients. | 2011 | Atherosclerosis | pmid:22015178 |
| Pedersen ER et al. | Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris. | 2010 | Atherosclerosis | pmid:20621297 |
| Van Campenhout A and Golledge J | Osteoprotegerin, vascular calcification and atherosclerosis. | 2009 | Atherosclerosis | pmid:19007931 |
| Ziegler S et al. | Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease. | 2005 | Atherosclerosis | pmid:16115489 |
| Erkol A et al. | Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. | 2012 | Atherosclerosis | pmid:22265272 |
| Vik A et al. | Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans. | 2007 | Atherosclerosis | pmid:16620835 |
| Dimitrow PP | Aortic valve stenosis as a complex inflammatory-hematological-osteogenic disease. | 2010 | Atherosclerosis | pmid:20864109 |
| Ohmori R et al. | Association between osteoprotegerin gene polymorphism and coronary artery disease in Japanese men. | 2006 | Atherosclerosis | pmid:16678184 |
| Secchiero P et al. | An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction. | 2010 | Atherosclerosis | pmid:20015493 |
| Pal SN et al. | Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. | 2010 | Atherosclerosis | pmid:20004897 |
| Asanuma Y et al. | Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. | 2007 | Atherosclerosis | pmid:17570371 |
| Golledge J et al. | Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification. | 2008 | Atherosclerosis | pmid:17675038 |
| Ali Z et al. | Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites. | 2009 | Atherosclerosis | pmid:19423112 |
| Chang YC and Zhao JH | Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. | 2011 | Aust Dent J | pmid:22126345 |
| Ozçaka O et al. | Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients. | 2010 | Aust Dent J | pmid:21133939 |
| Pereda GO et al. | Inflammatory and bone regulators expression in murine macrophages under exposure of commercial and experimental mineral trioxide aggregate. | 2012 | Aust Dent J | pmid:22924350 |
| Curl L and Sampson W | The presence of TNF-alpha and TNFR1 in aseptic root resorption. A preliminary study. | 2011 | Aust Orthod J | pmid:22372265 |
| Curl L et al. | A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation. | 2012 | Aust Orthod J | pmid:23304971 |
| Nybo M et al. | Rosiglitazone decreases plasma levels of osteoprotegerin in a randomized clinical trial with type 2 diabetes patients. | 2011 | Basic Clin. Pharmacol. Toxicol. | pmid:21726411 |
| Zhang D et al. | [Expression of OPG and RANKL at protein level in human periodontal ligament cells and the effect of 1alpha,25(OH)(2) vitamin D(3) on the secretion of OPG protein in vitro]. | 2004 | Beijing Da Xue Xue Bao | pmid:15605102 |
| Zhao NN et al. | [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. | 2012 | Beijing Da Xue Xue Bao | pmid:22353912 |
| Han J et al. | [Determination of bone metabolic marker levels in perio-implant crevicular fluid and analysis of dental implants stability by resonance frequency in the early stage of healing]. | 2015 | Beijing Da Xue Xue Bao | pmid:25686326 |
| Fan R et al. | [Expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in chronic apical periodontitis]. | 2008 | Beijing Da Xue Xue Bao | pmid:18278135 |
| Cui NH et al. | [Osteoclastic bone destruction and its regulating factors in oral squamous cell carcinoma]. | 2007 | Beijing Da Xue Xue Bao | pmid:17304322 |
| Tang XL et al. | [Effect of 17-beta estradiol on the expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin of human periodontal ligament cells during their osteogenic differentiation]. | 2007 | Beijing Da Xue Xue Bao | pmid:17304327 |
| Wang EB et al. | [Histochemical and immunohistochemical double staining for osteolytic related factors in keratocystic odontogenic tumor]. | 2010 | Beijing Da Xue Xue Bao | pmid:20140051 |
| Geusens P and Reid D | Newer drug treatments: their effects on fracture prevention. | 2005 | Best Pract Res Clin Rheumatol | pmid:16301192 |
| Mogi M and Kondo A | Down-regulation of mTOR leads to up-regulation of osteoprotegerin in bone marrow cells. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19393224 |
| Tanaka H et al. | Expression of RANKL/OPG during bone remodeling in vivo. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21771583 |
| Chen XW et al. | Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12150965 |
| Mukohyama H et al. | The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10777696 |
| Lorget F et al. | Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12163011 |
| Kobayashi-Sakamoto M et al. | NF-kappaB-dependent induction of osteoprotegerin by Porphyromonas gingivalis in endothelial cells. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15013432 |
| Ishii T et al. | Osteopontin as a positive regulator in the osteoclastogenesis of arthritis. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15033472 |
| Mancini L et al. | Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin. | 2000 | Biochem. Biophys. Res. Commun. | pmid:11118297 |
| Kreja L et al. | Mechanical regulation of osteoclastic genes in human osteoblasts. | 2008 | Biochem. Biophys. Res. Commun. | pmid:18243138 |
| Hozumi A et al. | Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19324007 |
| Rachner TD et al. | 17beta-Estradiol inhibits osteoprotegerin production by the estrogen receptor-alpha-positive human breast cancer cell line MCF-7. | 2008 | Biochem. Biophys. Res. Commun. | pmid:18252198 |
| Nakashima T et al. | Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10973797 |
| Akiyama T et al. | PEDF regulates osteoclasts via osteoprotegerin and RANKL. | 2010 | Biochem. Biophys. Res. Commun. | pmid:19945427 |
| Brändström H et al. | A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054556 |
| Wittrant Y et al. | Osteoprotegerin differentially regulates protease expression in osteoclast cultures. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054560 |
| Makhluf HA et al. | Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10679262 |
| Penno H et al. | Osteoprotegerin secretion from prostate cancer is stimulated by cytokines, in vitro. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054622 |
| Fu M et al. | Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12056809 |
| Schoppet M et al. | TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathy. | 2005 | Biochem. Biophys. Res. Commun. | pmid:16288714 |
| Chikatsu N et al. | Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10631114 |
| Mazière C et al. | Oxidized low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress. | 2013 | Biochem. Biophys. Res. Commun. | pmid:24070606 |
| Singh PP et al. | Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors. | 2012 | Biochem. Biophys. Res. Commun. | pmid:22561018 |
| Hofbauer LC et al. | Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9784422 |
| Matsuzaki K et al. | Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9600092 |
| Miyamoto A et al. | Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9464281 |
| Tomoyasu A et al. | Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9571159 |
| Akatsu T et al. | Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9753612 |
| Hakeda Y et al. | Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9790989 |
| Nagai M and Sato N | Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10208850 |
| Grundt A et al. | Direct effects of osteoprotegerin on human bone cell metabolism. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19748486 |
| Tsukii K et al. | Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9610359 |
| Mizuno A et al. | Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9647741 |
| Brändström H et al. | Tumor necrosis factor-alpha and -beta upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9703945 |
| Son J et al. | cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20599715 |
| Vidal ON et al. | Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9703989 |
| Brändström H et al. | Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9642127 |
| Schoppet M et al. | Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21371424 |
| Itonaga I et al. | 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10529407 |
| Nakagawa N et al. | Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10548488 |
| Notoya M et al. | Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15474477 |
| Nakagawa N et al. | Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10548507 |
| Ito H et al. | Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10462495 |
| Chen TH et al. | Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cells. | 2007 | Biochem. Biophys. Res. Commun. | pmid:17331472 |
| Murakami T et al. | Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9837778 |
| Makiishi-Shimobayashi C et al. | Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11181055 |
| Kaneuji T et al. | Mechanisms involved in regulation of osteoclastic differentiation by mechanical stress-loaded osteoblasts. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21459078 |
| Kwon OH et al. | The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors. | 2005 | Biochem. Biophys. Res. Commun. | pmid:16083856 |
| Théoleyre S et al. | Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16828054 |
| Hofbauer LC et al. | Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11162519 |
| Brändström H et al. | Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11162596 |
| Jacobson A et al. | Vitamin A differentially regulates RANKL and OPG expression in human osteoblasts. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15313187 |
| Yano K et al. | Immunological study on circulating murine osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF): possible role of OPG/OCIF in the prevention of osteoporosis in pregnancy. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11594776 |
| Pantouli E et al. | Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells. | 2005 | Biochem. Biophys. Res. Commun. | pmid:15721297 |
| Lee ZH and Kim HH | Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. | 2003 | Biochem. Biophys. Res. Commun. | pmid:12745060 |
| Pullisaar H et al. | Simvastatin coating of TiOâ‚‚ scaffold induces osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells. | 2014 | Biochem. Biophys. Res. Commun. | pmid:24704451 |
| Subramaniam M et al. | TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20059964 |
| Tang L et al. | Effects of different magnitudes of mechanical strain on Osteoblasts in vitro. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16603128 |
| Viereck V et al. | Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. | 2002 | Biochem. Biophys. Res. Commun. | pmid:11855844 |
| Yang X et al. | Protein Kinase C is a mediator of the synthesis and secretion of osteoprotegerin in osteoblast-like cells. | 2002 | Biochem. Biophys. Res. Commun. | pmid:11779130 |
| Oue E et al. | CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction. | 2012 | Biochem. Biophys. Res. Commun. | pmid:22771802 |
| Boissy P et al. | RANKL induces formation of avian osteoclasts from macrophages but not from macrophage polykaryons. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11606048 |
| Park H et al. | Phosphodiesterase 4 inhibitor regulates the TRANCE/OPG ratio via COX-2 expression in a manner similar to PTH in osteoblasts. | 2007 | Biochem. Biophys. Res. Commun. | pmid:17222389 |
| Bridgham JT and Johnson AL | Characterization of chicken TNFR superfamily decoy receptors, DcR3 and osteoprotegerin. | 2003 | Biochem. Biophys. Res. Commun. | pmid:12878204 |
| Matayoshi T et al. | Neuropeptide substance P stimulates the formation of osteoclasts via synovial fibroblastic cells. | 2005 | Biochem. Biophys. Res. Commun. | pmid:15649411 |
| Yasuhara R et al. | Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D3-induced osteoclast differentiation by degrading osteoprotegerin. | 2009 | Biochem. J. | pmid:19102726 |
| Xu D et al. | Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members. | 2004 | Biochem. J. | pmid:15250821 |